Related Experiment Video
Updated: Aug 12, 2025

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Phosphorylation of rpS3 by Lyn increases translation of Multi-Drug Resistance (MDR1) gene
Woo Sung Ahn1, Hag Dong Kim2, Tae Sung Kim1
1Laboratory of Biochemistry, Division of Life Sciences, Korea University, Seoul 02841, Korea.
Abstract:
Lyn, a tyrosine kinase that is activated by double-stranded DNAdamaging agents, is involved in various signaling pathways, such as proliferation, apoptosis, and DNA repair. Ribosomal protein S3 (RpS3) is involved in protein biosynthesis as a component of the ribosome complex and possesses endonuclease activity to repair damaged DNA. Herein, we demonstrated that rpS3 and Lyn interact with each other, and the phosphorylation of rpS3 by Lyn, causing ribosome heterogeneity, upregulates the translation of p-glycoprotein, which is a gene product of multidrug resistance gene 1. In addition, we found that two different regions of the rpS3 protein are associated with the SH1 and SH3 domains of Lyn. An in vitro immunocomplex kinase assay indicated that the rpS3 protein acts as a substrate for Lyn, which phosphorylates the Y167 residue of rpS3. Furthermore, by adding various kinase inhibitors, we confirmed that the phosphorylation status of rpS3 was regulated by both Lyn and doxorubicin, and the phosphorylation of rpS3 by Lyn increased drug resistance in cells by upregulating p-glycoprotein translation. [BMB Reports 2023; 56(5): 302-307].
Insights
Lyn tyrosine kinase phosphorylates ribosomal protein S3 (RpS3), enhancing p-glycoprotein translation and increasing multidrug resistance. This interaction reveals a novel mechanism in cellular drug resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Lyn is a tyrosine kinase activated by DNA damage, regulating key cellular processes.
- Ribosomal protein S3 (RpS3) has endonuclease activity for DNA repair and is part of protein biosynthesis.
- Multidrug resistance (MDR) is a significant challenge in cancer therapy, often mediated by p-glycoprotein.
Discussion:
- This study reveals a direct interaction between Lyn and RpS3.
- Lyn phosphorylates RpS3 at the Y167 residue, influencing ribosome function and protein translation.
- This phosphorylation event upregulates the translation of p-glycoprotein, a key mediator of MDR.
Key Insights:
- RpS3 acts as a substrate for Lyn, with distinct protein regions interacting with Lyn's SH1 and SH3 domains.
- The phosphorylation of RpS3 by Lyn is regulated by both the kinase and doxorubicin.
- This Lyn-mediated phosphorylation of RpS3 enhances cellular drug resistance by increasing p-glycoprotein translation.
Outlook:
- Further investigation into the structural basis of the Lyn-RpS3 interaction could yield new therapeutic targets.
- Understanding this pathway may lead to strategies to overcome drug resistance in cancer.
- Exploring the role of ribosome heterogeneity in drug resistance warrants further study.
Related Concept Videos
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Translational Regulation
PI3K/mTOR/AKT Signaling Pathway
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
MAPK Signaling Cascades
Transcriptional Regulation: Riboswitches

